Skip To Main Content
Yingzhen Bian on Muck Rack

Yingzhen Bian

As seen in: BMC Cancer, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingzhen

Contact Yingzhen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma - BMC Cancer

|
By Yingzhen Bian, Haizhou Liu, Zhaorong Feng, Yanyan Lin, Jilin Li, Litu Zhang, Jinglei Huang
| BMC Cancer Verified
This study included 93 patients with L858R in LUAD and 220 patients with 19DEL mutation admitted to the Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital from July 2008 to July 2021. Four L858R patients and 16 19DEL patients were excluded due to incomplete clinical information. Eight 19DEL patients with exon 20 mutations were also excluded (Fig. 1A).
Open in Who Shared Issue with article?

Role of serum CYFRA 21-1

|
By Shirong Li, Wene Wei, Zhaorong Feng, Yingzhen Bian
| Dove Medical Press
Back to Journals » Cancer Management and Research » Volume 15 Authors Li S, Wei W, Feng Z, Bian Y, Pan J, Mai J, Ning S, Huang J, Gao X, Zhang L Received 17 March 2023 Accepted for publication 30 June 2023 Published 6 July 2023 Volume 2023:15 Pages 601—614 DOI https://doi.org/10.2147/CMAR.S410477 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Sanjeev K.
Open in Who Shared Issue with article?
See all 2 articles